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echanisms of neurogenic regulation of vascular tone and of
ormonal and metabolic processes, which we did not evaluate in
ur study.
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ubris Versus Evidence
ang et al. (1) from the Mayo Clinic have made a valuable
ontribution to the growing evidence supporting the current safety
f percutaneous coronary intervention (PCI). Unfortunately, in the
ccompanying editorial, Bittl (2) digresses from this evidence to
ttribute “hubris” (arrogance resulting from excessive pride) to
hose who support PCI at qualified hospitals with off-site surgical
ackup.
Abundant recent data demonstrate the safety of PCI at qualified
ospitals with off-site backup (3,4), which neither Bittl (2) nor the
CI guidelines evaluate. This steadily growing practice is sup-
orted by many thought-leaders with no perceived hubris (cited
lsewhere [4]), including Singh, the senior author of the present
eport (5), by the guidelines of five other countries, and (tacitly) by
he European Society of Cardiology (6). The only negative study
6ited by the guidelines is based on claims-coding Medicare data
nd pertains only to “non-primary/rescue” PCI at ultra-low vol-
me sites (50 Medicare PCIs/year) (7).
The speculation that emergency surgery after PCI would be
ore frequent at non-“premier” centers neglects the available data
nd is based on theoretical arguments. The notion that most
ospitals cannot replicate the outcomes at the Mayo Clinic is
nfounded. In fact, the Mayo Clinic itself supports PCI at off-site
ospitals; these have had no surgical emergencies in 1,700 proce-
ures (5). It should be recognized that satellite hospitals are
nherently motivated to use the most careful case-selection (5) and
enerally do not perform the most complex procedures nor use
igher-risk equipment. A fundamental paradox is built into the
CI guidelines themselves, in that they accept off-site backup only
or primary PCI but not for nonemergent PCI despite their
dvocacy of higher procedural volumes to improve quality.
The assertion that the surgeon’s presence in the catheterization
aboratory after a complication somehow lessens the patient’s risk
ompared to a direct telephone conversation between colleagues is
nly theoretical and ignores the reality that even on-site PCI
omplications may occur when the surgeon is occupied in the
perating room, is in an off-site office, or is at home during
ff-hours.
Indeed, the very intensity of this debate over surgical backup,
eplete with inappropriate rhetoric, might suggest that there are
ther agendas being raised by this question that have little to do
ith the published data.
In this era when the importance of evidence-based medicine is
niversally recognized, proffering speculation as established con-
lusions while ignoring considerable data could itself be considered
form of “academic hubris.” The advantages of increased access,
ncreased procedural volumes, and the resultant shorter door-to-
alloon times that are documented for PCI at nonsurgical hospitals
8) may far outweigh any proposed disadvantages of offering both
rimary and nonemergent PCI with off-site backup.
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EPLY
am grateful to Dr.Wharton for his interest in the editorial (1) about
he declining need for emergency bypass surgery for failed percuta-
eous coronary interventions (PCIs) at the Mayo Clinic (2).
The Mayo report (2) and the current PCI guidelines raise the
ssue of what constitutes adequate evidence to perform elective
CIs in community hospitals without on-site bypass surgery.
lthough Wharton et al. (3) showed that direct PCI is superior to
brinolytic therapy for ST-segment elevation myocardial infarc-
ion in a broad range of hospital settings, this level of evidence is
urrently lacking for elective PCIs without on-site bypass surgery
n the U.S. The Mayo report (2) does not prove that it is safe to
erform elective PCIs without on-site surgery in Exeter, New
ampshire, or anywhere else.
The assessment of elective PCIs without on-site bypass surgery
nderway in some states (4) is a step in the right direction.
owever, choosing the right metrics is challenging. An observa-
ional matched cohort analysis constitutes a good start, but results
rom a single pair of closely linked hospitals within one health care
elivery system are not broadly generalizable (5), and statistical
ests for non-inferiority require larger comparison groups.
The motivation to perform an elective PCI without on-site
ypass surgery needs clarification. “During its 28-year-history,
lective PCI has never been shown to extend life or prevent death”
4). The recent proliferation of cardiac procedures in North
merica has not been explained by an increased prevalence of
isease but has generated serious questions about the value to
ndividual patients and society (6). Costs will increase further in
he absence of safeguards to limit the inevitable expansion in the
umber of hospitals performing PCIs.
Finally, the term “hubris” in the editorial (1) has rankled some
eaders. The medical meaning, based on the classical character flaw
f arrogantly flaunting natural law and suffering tragic conse-
uences, connotes more than the dictionary definition. Even the
ost gifted physicians can be humbled by unforeseeable twists and
urns in the response to treatment. But I digress.
John A. Bittl, MD
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r. Wharton’s letter resonates with our practice at two regional
ites with no on-site surgery (1). None of us is immune from
ubris, but by the same token, none of us is either above or below
t (as the case may be), selecting only specific data points on a curve
hat agree with what we hold to be the “truth.” A single publication
r a trial rarely reveals the entire truth, and more data are needed
o discover concordance in the findings. When the results of
ultiple datasets are similar in directionality, degree, and extent,
e can be increasingly confident that we know the answer to the
pecific question posed. We need to remember that the questions
volve as do the answers.
Thus, we agree wholeheartedly with Dr. Wharton about “grow-
ng evidence supporting the current safety of percutaneous coro-
ary intervention [PCI] . . . with off-site surgical backup.” The
hallenge is to increase safe access to this important part of our
herapeutic armamentarium. Programs that have been performing
ff-site PCIs have found that success depends on: 1) careful patient
nd lesion selection; 2) a protocol to rapidly transport patients with
CI complications to centers with on-site surgery; 3) skilled
perators and catheterization laboratory staff who are able to
erform these procedures with a high success rate; and 4) processes
f the patient’s care that will improve the outcomes following PCI.
t will be prudent to establish guidelines for elective PCIs similar
o those proposed by Dr. Wharton for the conduct of primary
CIs (2).
Until further studies evaluating the safety of off-site PCI can be
erformed, we ask all cardiologists to practice another Greek word,
nochi, which means “tolerance.” In other words, cardiologists
hould keep an open mind regarding the performance of PCI
ithout surgical backup until further data are available.
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